Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class ASSE: 600332

"Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited"Indicative Announcement on Change in Equity Structure of Controlling Shareholder

Sep 22, 2026 · Issued by Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class A via Shanghai Stock Exchange

Indicative Announcement on Change in Equity Structure of Controlling Shareholder

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class A

"Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited"Announcement on Changes to Matters Concerning the Equity Investment Fund and Progress of the Related Party TransactionSep 12
"Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited"Announcement on Receipt of the Drug Registration Certificate in Macao by Guangzhou Baiyunshan Bioproducts Co., Ltd.Sep 9
"Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited"Announcement on Convening the 2026 Semi-annual Performance BriefingSep 5
"Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited"Announcement on Implementation of Dividend Distribution for the First Half of 2026Sep 4

All Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class A news releases